These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7107545)

  • 21. Penicillin gets some help against resistant pathogens.
    Henehan J
    JAMA; 1982 Nov; 248(19):2427. PubMed ID: 6922944
    [No Abstract]   [Full Text] [Related]  

  • 22. Further data on augmentin and co-trimoxazole in the treatment of urinary tract infection.
    Matts SG; Fancourt GJ; Mitchell CJ; Gowers E; Boston PF
    Br J Clin Pract; 1985 May; 39(5):179-84. PubMed ID: 3907682
    [No Abstract]   [Full Text] [Related]  

  • 23. Augmentin-nice idea, but more trials please.
    Drug Ther Bull; 1982 Mar; 20(6):21-3. PubMed ID: 7075472
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effectiveness and tolerance of amoxicillin/clavulanic acid ("Augmentin") in intravenous injections in adults].
    el Filali KM; el M'Daghri N; el Kabli H; Hajji M; Benbachir M; Himmich H
    Pharmatherapeutica; 1989; 5(5):329-37. PubMed ID: 2748691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changing role of co-trimoxazole in the treatment of recurrent urinary infections: a comparison with augmentin.
    Brumfitt W; Hamilton-Miller JM
    Br J Clin Pract; 1985 Sep; 39(9):346-51. PubMed ID: 3904797
    [No Abstract]   [Full Text] [Related]  

  • 26. [Augmentin].
    Foster M
    Antibiot Khimioter; 1992 Sep; 37(9):3-9. PubMed ID: 1444667
    [No Abstract]   [Full Text] [Related]  

  • 27. [A combination of amoxycillin with clavulanic acid (Augmentin) in various types of urinary tract infections caused by microbes producing beta-lactamase].
    Prát V; Horcicková M; Hatala M; Liska M; Matousovic K
    Cas Lek Cesk; 1985 Jun; 124(23):711-4. PubMed ID: 3874692
    [No Abstract]   [Full Text] [Related]  

  • 28. [Amoxycillin/potassium clavulanate (augmentin)--current importance in the treatment of infection].
    Fomina IP
    Antibiot Khimioter; 1997; 42(9):36-43. PubMed ID: 9412419
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy and safety of pharmacokinetically enhanced amoxicillin-clavulanate at 2,000/125 milligrams twice daily for 5 days versus amoxicillin-clavulanate at 875/125 milligrams twice daily for 7 days in the treatment of acute exacerbations of chronic bronchitis.
    Sethi S; Breton J; Wynne B
    Antimicrob Agents Chemother; 2005 Jan; 49(1):153-60. PubMed ID: 15616290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Augmentin (amoxycillin and clavulanic acid) therapy in complicated infections due to beta-lactamase producing bacteria.
    Leigh DA; Bradnock K; Marriner JM
    J Antimicrob Chemother; 1981 Mar; 7(3):229-36. PubMed ID: 6974165
    [No Abstract]   [Full Text] [Related]  

  • 31. Effectiveness of intravenous Augmentin in the treatment of thalassaemic patients with Yersinia enterocolitica infection.
    Kattamis C; Syriopoulou V; Hadjiminas J; Tsivitanidou-Kacourou T
    J Antimicrob Chemother; 1984 Sep; 14(3):303-5. PubMed ID: 6490574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the field of otorhinolaryngology].
    Kawamura S; Sugita R; Fujimaki Y; Deguchi K
    Jpn J Antibiot; 1983 Mar; 36(3):500-8. PubMed ID: 6553606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amoxicillin-potassium clavulanate: rational pharmacology meets clinical infectious disease.
    Reed MD; Blumer JL
    Clin Pharm; 1984; 3(6):653-4. PubMed ID: 6509880
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical experience with intravenous Augmentin in the treatment of paediatric infections.
    Ploechl E; Huber EG
    J Int Med Res; 1986; 14(3):153-7. PubMed ID: 3636248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Augmentin (amoxycillin-clavulanic acid) compared with co-trimoxazole in urinary tract infections.
    Fancourt GJ; Matts SG; Mitchell CJ
    Br Med J (Clin Res Ed); 1984 Jul; 289(6437):82-3. PubMed ID: 6428687
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative efficacy and safety of oral fleroxacin and amoxicillin/clavulanate potassium in skin and soft tissue infections.
    Tassler H
    Am J Med; 1993 Mar; 94(3A):159S-165S. PubMed ID: 8452174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of uncomplicated gonococcal urethritis in males with two doses of Augmentin, six hours apart.
    Bee LH; Phang T
    Singapore Med J; 1985 Apr; 26(2):147-9. PubMed ID: 3898395
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of augmentin on sputum beta-lactamase activity in patients with cystic fibrosis.
    Penketh AR; Hodson ME; Batten JC
    Br J Clin Pract; 1984 May; 38(5):188-9. PubMed ID: 6610437
    [No Abstract]   [Full Text] [Related]  

  • 39. [Augmentin and respiratory tract infections in the adult: current aspects].
    Chidiac C
    Presse Med; 2000 Sep; 29(26 Suppl):3-4. PubMed ID: 11045110
    [No Abstract]   [Full Text] [Related]  

  • 40. [Augmentin--current and prospective therapeutic indications].
    Mihălţan F
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1988; 37(3):203-10. PubMed ID: 2855664
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.